• Profile
Close

Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy

Archives of Gynecology and Obstetrics Sep 18, 2017

Kozaki M, et al. - This study is performed to examine the predictive factors for the impacts of chemotherapy and prognostic factors in these patients. The outcome of this study suggests therapy-free interval (TFI) has predictive value for response to chemotherapy and prognosis of patients with recurrent cervical cancer after definitive CCRT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay